| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41366-018-0083-4 |
| P698 | PubMed publication ID | 29777233 |
| P50 | author | Kazuhiko Koike | Q21699620 |
| P2093 | author name string | Kei Saito | |
| Hiroyuki Isayama | |||
| Minoru Tada | |||
| Yousuke Nakai | |||
| Naoto Hayashi | |||
| Hirofumi Kogure | |||
| Naminatsu Takahara | |||
| Suguru Mizuno | |||
| Takeharu Yoshikawa | |||
| P2860 | cites work | A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects | Q39674136 |
| Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). | Q40310151 | ||
| Prostate cancer and adiponectin. | Q40418631 | ||
| Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010. | Q41584008 | ||
| PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | Q42826174 | ||
| Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study | Q43276256 | ||
| Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients | Q46665419 | ||
| Effects of pitavastatin on adiponectin in patients with hyperlipidemia | Q46708651 | ||
| Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort | Q47308634 | ||
| New criteria for 'obesity disease' in Japan. | Q53667063 | ||
| Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms | Q56989560 | ||
| The association of circulating adiponectin levels with pancreatic cancer risk: A study within the prospective EPIC cohort | Q57271342 | ||
| Incidental pancreatic cysts found by magnetic resonance imaging and their relationship with pancreatic cancer | Q57643686 | ||
| Incidental pancreatic cysts on 3D turbo spin echo magnetic resonance cholangiopancreatography: prevalence and relation with clinical and imaging features | Q57644742 | ||
| Prevalence of incidental pancreatic cysts in the adult population on MR imaging | Q57645260 | ||
| Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis | Q80492462 | ||
| Prevalence of Pancreatic Cystic Lesions Is Associated With Diabetes Mellitus and Obesity: An Analysis of 5296 Individuals Who Underwent a Preventive Medical Examination | Q88302177 | ||
| Diagnosis and Classification of Diabetes Mellitus | Q22255454 | ||
| Current perspectives between metabolic syndrome and cancer | Q26749299 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Global trend in overweight and obesity and its association with cardiovascular disease incidence | Q27027564 | ||
| Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
| Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study | Q28193386 | ||
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity | Q29616103 | ||
| Adiponectin and adiponectin receptors | Q29620248 | ||
| Development of automatic visceral fat volume calculation software for CT volume data | Q30811792 | ||
| Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia | Q33556805 | ||
| New insight into adiponectin role in obesity and obesity-related diseases | Q33943727 | ||
| Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece | Q34182815 | ||
| Adiponectin and breast cancer risk | Q34303243 | ||
| Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study | Q34892998 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Pancreatic cancer biology and genetics | Q35013204 | ||
| Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? | Q35100662 | ||
| Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients | Q35494053 | ||
| Adiponectin: a key fat-derived molecule regulating inflammation | Q36150821 | ||
| A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts | Q36535684 | ||
| Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. | Q36543768 | ||
| Adiponectin as an anti-inflammatory factor | Q36753830 | ||
| Abdominal obesity and the risk of esophageal and gastric cardia carcinomas | Q37163349 | ||
| Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers | Q37289092 | ||
| High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations | Q37771750 | ||
| Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies | Q37926319 | ||
| Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. | Q38284057 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 169-175 | |
| P577 | publication date | 2018-05-17 | |
| P1433 | published in | International Journal of Obesity | Q6051519 |
| P1476 | title | Visceral adiposity and high adiponectin levels are associated with the prevalence of pancreatic cystic lesions | |
| P478 | volume | 43 |
Search more.